ImmuCell Corporation stock is down -0.95% since 30 days ago. The next earnings date is Feb 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.93% of the previous 28 December’s closed higher than November.
ImmuCell Corporation develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine which quarter of the udder is mastitic.